Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), today announced that it has achieved a milestone under its worldwide licensing and collaboration agreement ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE